Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/23723556.2016.1217967 http://scihub22266oqcxt.onion/10.1080/23723556.2016.1217967 C5286961!5286961!28197530     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Cell+Oncol 2017 ; 4 (1): ä Nephropedia Template TP {{tp|p=28197530|t=2017. Mutant p53?Nrf2 axis regulates the proteasome machinery in cancer |pdf=|usr=}}{{28197530}} gab.com Text Mutant p53 Nrf2 axis regulates the proteasome machinery in cancer JO: Mol Cell Oncol http://www.kidney.de/pget.php?&tw=1&pmid=28197530 #FOAvip The proteasome machinery is a common target of gain-of-function p53 missense mutants. Upregulation of the proteasome fosters chemoresistance to proteasome inhibitors. In triple negative breast cancer cells this resistance mechanism, namely the Nrf2-regulated ?bounce-back? response to proteasome inhibitors, can be overcome by targeting p53 mutant proteins with APR-246/PRIMA-1Met. Twit Text FOAVip Mutant p53 Nrf2 axis regulates the proteasome machinery in cancer ????Mol Cell Oncol http://www.kidney.de/pget.php?&tw=1&pmid=28197530 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28197530 #FOAvip English Wikipedia <ref>{{Cite pmid|28197530}}</ref> Mutant p53?Nrf2 axis regulates the proteasome machinery in cancer #MMPMID28197530 Lisek K; Walerych D; Del Sal G Mol Cell Oncol 2017[]; 4 (1): ä PMID28197530show ga The proteasome machinery is a common target of gain-of-function p53 missense mutants. Upregulation of the proteasome fosters chemoresistance to proteasome inhibitors. In triple negative breast cancer cells this resistance mechanism, namely the Nrf2-regulated ?bounce-back? response to proteasome inhibitors, can be overcome by targeting p53 mutant proteins with APR-246/PRIMA-1Met. äMutant p53?Nrf2 axis regulates the proteasome machinery in cancer (epmc).pdf DeepDyve Pubget Overpricing